Test
MD21 Implantable Drug Delivery Systems (IDDS)
Este test tiene tipos de pregunta que se abren en el reproductor de siempre.
Preguntas del test (8)
1IDDS are useful for drugs that [blank_start]cannot be delivered[blank_end] via the oral route, drugs that are [blank_start]irregularly absorbed[blank_end] via the gastrointestinal tract, or drugs that benefit from [blank_start]site-specific[blank_end] dosing(examples include steroids, chemotherapeutics, antibiotics, analgesics, and contraceptives.) Because of site specificity, [blank_start]lower[blank_end] doses can be used and therefore less [blank_start]side effects[blank_end] are experienced. IDDS also improve patient [blank_start]compliance[blank_end].
- Acannot be delivered
- Birregularly absorbed
- Csite-specific
- Dlower
- Eside effects
- Fcompliance
2IDDS potential drawbacks:
• Require [blank_start]minor surgery[blank_end]
• [blank_start]Cost/benefit[blank_end] ratio
• May require [blank_start]specialized training[blank_end]
• Regulatory path for approval [blank_start]longer[blank_end]
• [blank_start]Pain[blank_end] and discomfort- Aminor surgery
- BCost/benefit
- Cspecialized training
- Dlonger
- EPain
3Polymers are used for IDDS because they are easily fabricated, have easily tuned degradation kinetics, and are biocompatible.
- AVerdadero
- BFalso
4Non-degradable IDDS include the matrix (diffusion) controlled system and the membrane enclosed reservoir system.
The matrix system involves a polymer containing drug, with [blank_start]pores[blank_end], that swells /expands [blank_start]uniformly[blank_end]. This allows drug to [blank_start]diffuse[blank_end] from pores.
The reservoir system involves a compact polymer matrix [blank_start]core[blank_end] with drug surrounded by a non-degradable semi-permeable [blank_start]membrane[blank_end]. Swelling of the membrane barrier is [blank_start]non-uniform[blank_end] and allows for water to permeate in and drug components to diffuse out. Thickness and permeability properties can
control drug diffusion into the body.- Apores
- Buniformly
- Cdiffuse
- Dcore
- Emembrane
- Fnon-uniform
5Membrane enclosed reservoirs can be used for many things. Which of these are they not typically used for?
- ABirth control (eg IUD)
- BVascular disease (eg drug eluting stent)
- COccular treatment (eg pilocarpine ring)
- DAnalgesia (eg ibuprofen insert)
6In biodegradable IDDS drug is [blank_start]homogeneously[blank_end] mixed within a biodegradable polymer, which is subsequently moulded into a shape. The advantages of biodegradable IDDS is that there is [blank_start]no need for removal surgery[blank_end], as the degraded [blank_start]metabolites[blank_end] are safely [blank_start]excreted or absorbed[blank_end] by the body. The polymers in these IDDS have [blank_start]labile[blank_end] bonds.
Typically, [blank_start]hydrolysis[blank_end] of the polymer causes drug release. Controlled release of the drug is achieved by the combination of [blank_start]polymer erosion[blank_end] (by hydrolysis) and [blank_start]diffusion of the drug[blank_end] through the polymer matrix.
The rate of drug release is determined by a) the rate of [blank_start]biodegradation[blank_end], b) polymer composition [blank_start]molecular weight[blank_end], c) drug [blank_start]loading[blank_end], and d) the drug polymer [blank_start]interactions[blank_end].- Ahomogeneously
- Bno need for removal surgery
- Cmetabolites
- Dexcreted or absorbed
- Elabile
- Fhydrolysis
- Gpolymer erosion
- Hdiffusion of the drug
- Ibiodegradation
- Jmolecular weight
- Kloading
- Linteractions
7Biodegradable Surface Erosion: degrades from the [blank_start]outer surface[blank_end] inward, uniformly.
Biodegradable Surface Erosion: degrades or deforms uniformly throughout the [blank_start]bulk[blank_end] of the material.- Aouter surface
- Bbulk
8Examples of biodegradable system IDDS for [blank_start]cancer treatments[blank_end]
• [blank_start]Gliadel[blank_end] wafer (to improve success and life expectancy after [blank_start]glioma[blank_end] removal in brain)
• [blank_start]Zoladex[blank_end] (advanced [blank_start]prostate and breast[blank_end] cancer, releases hormones)- Acancer treatments:
- Bglioma
- CGliadel
- DZoladex
- Eprostate and breast
Información
- Descripción
- (Medicines) PHCY211 Test sobre MD21 Implantable Drug Delivery Systems (IDDS), creado por Mer Scott el 22/05/2018.
- Autor
- Mer Scott
- Idioma
- English
- Visitas
- 4
- Etiquetas
- Valoración
- Aún sin valoraciones Valora este test